| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $24.6B | $23.9B | $6.4B | $31.5B | $29.5B | $22.3B | $4.9B | $5.4B |
| Cost of Revenue | $10.0B | $9.7B | $9.9B | $12.5B | $11.5B | $9.8B | $7.9B | $8.8B |
| Gross Profit | $14.5B | $14.2B | $3.8B | $18.9B | $18.0B | $12.5B | $2.7B | $3.0B |
| R&D Expense | $1.6B | $1.6B | $1.5B | $1.7B | $1.7B | $1.3B | $1.1B | $1.2B |
| SG&A Expense | $8.2B | $7.8B | $7.3B | $8.5B | $8.2B | $6.9B | $5.6B | $6.5B |
| Operating Income | $4.7B | $4.9B | $1.3B | $8.7B | $7.5B | $4.2B | $1.0B | $1.0B |
| Net Income | $3.6B | $3.9B | $4.8B | $7.2B | $6.4B | $3.6B | $3.0B | $0.7B |
| EPS (Basic) | $5.07 | $5.33 | $1.46 | $9.80 | $8.77 | $4.97 | $1.75 | $1.06 |
| EPS (Diluted) | $5.05 | $5.29 | $1.45 | $9.66 | $8.61 | $4.89 | $1.73 | $1.05 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $83.5B | $77.5B | $84.5B | $84.3B | $83.2B | $76.2B | $62.1B | $47.8B |
| Current Assets | $12.8B | $9.5B | $13.9B | $15.9B | $11.6B | $13.8B | $25.6B | $7.1B |
| Cash & Equivalents | — | — | — | — | — | — | $19.9B | $0.8B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $6.8B | $6.8B | $8.3B | $8.4B | $8.1B | $7.4B | $4.9B | $4.8B |
| Stockholders' Equity | $52.5B | $49.5B | $53.5B | $50.1B | $45.2B | $39.8B | $30.3B | $28.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6.4B | $6.7B | $7.2B | $8.5B | $8.4B | $6.2B | $4.0B | $4.0B |
| Investing Cash Flow | $-1.2B | $-2.0B | $-7.1B | $-2.2B | $-13.0B | $-21.2B | $-1.2B | $-2.9B |
| Capital Expenditures | $1.2B | $1.4B | $1.4B | $1.2B | $1.3B | $0.8B | $0.6B | $0.7B |
| Financing Cash Flow | $-3.0B | $-8.4B | $-0.3B | $-2.6B | $1.3B | $1.0B | $16.4B | $-0.8B |